Yakira Capital Management’s Acceleron Pharma XLRN Stock Holding History

Yakira Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,750	Closed	-$3.74M	–	494
2021 Q3	$3.74M	Buy	+21,750	New	+$2.84M	0.58%	48

Yakira Capital Management's XLRN Position: Q4 2021 in Review

Yakira Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 21,750 shares — an estimated $3.74M sold.

Yakira Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $3.74M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Yakira Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Yakira Capital Management sold 21,750 Acceleron Pharma shares in Q4 2021, an estimated $3.74M.
Yakira Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Yakira Capital Management's Acceleron Pharma position peaked at $3.74M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Yakira Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.